Research programme: Hedgehog cell-signalling pathway inhibitors - MAX BioPharmaAlternative Names: Hedgehog signalling pathway antagonists - MAX BioPharma; Liver X receptor agonists - MAX BioPharma; Oxysterol LXR agonists - MAX BioPharma
Latest Information Update: 15 Oct 2013
At a glance
- Originator MAX BioPharma
- Class Small molecules; Sterols
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors; Liver X receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Multiple myeloma; Pancreatic cancer
Most Recent Events
- 07 Oct 2013 Preclinical trials in Multiple myeloma in USA (unspecified route)
- 07 Oct 2013 Preclinical trials in Pancreatic cancer in USA (unspecified route)